Gyre Therapeutics (GYRE) Total Debt: 2009-2016
Historic Total Debt for Gyre Therapeutics (GYRE) over the last 7 years, with Sep 2016 value amounting to $28,000.
- Gyre Therapeutics' Total Debt fell 95.86% to $28,000 in Q3 2016 from the same period last year, while for Sep 2016 it was $28,000, marking a year-over-year decrease of 95.86%. This contributed to the annual value of $1.2 million for FY2015, which is N/A change from last year.
- Per Gyre Therapeutics' latest filing, its Total Debt stood at $28,000 for Q3 2016, which was down 78.46% from $130,000 recorded in Q2 2016.
- Gyre Therapeutics' 5-year Total Debt high stood at $2.7 million for Q1 2012, and its period low was $28,000 during Q3 2016.
- Moreover, its 3-year median value for Total Debt was $577,000 (2014), whereas its average is $535,125.
- Per our database at Business Quant, Gyre Therapeutics' Total Debt skyrocketed by 41.42% in 2015 and then plummeted by 95.86% in 2016.
- Gyre Therapeutics' Total Debt (Quarterly) stood at $2.0 million in 2012, then crashed by 42.83% to $1.1 million in 2013, then crashed by 64.62% to $478,000 in 2014, then skyrocketed by 41.42% to $1.2 million in 2015, then tumbled by 95.86% to $28,000 in 2016.
- Its Total Debt stands at $28,000 for Q3 2016, versus $130,000 for Q2 2016 and $196,000 for Q1 2016.